It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
出版年份 2022 全文链接
标题
It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
作者
关键词
-
出版物
Frontiers in Cell and Developmental Biology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-01-26
DOI
10.3389/fcell.2022.818744
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR)
- (2021) Maya Maor-Nof et al. CELL
- Viral strategies for circumventing p53
- (2021) Camila Martin Cardozo et al. CURRENT OPINION IN ONCOLOGY
- Differential requirements for MDM2 E3 activity during embryogenesis and in adult mice
- (2021) Timothy J. Humpton et al. GENES & DEVELOPMENT
- Distinct mechanisms control genome recognition by p53 at its target genes linked to different cell fates
- (2021) Marina Farkas et al. Nature Communications
- Hypothermia effectively treats tumors with temperature-sensitive p53 mutations
- (2021) Junhao Lu et al. CANCER RESEARCH
- Trends in peptide drug discovery
- (2021) Markus Muttenthaler et al. NATURE REVIEWS DRUG DISCOVERY
- Proteogenomics drives therapeutic hypothesis generation for precision oncology
- (2021) Jonathan T. Lei et al. BRITISH JOURNAL OF CANCER
- Widespread displacement of DNA‐ and RNA‐binding factors underlies toxicity of arginine‐rich cell‐penetrating peptides
- (2021) Vanesa Lafarga et al. EMBO JOURNAL
- PRMT1 promotes the tumor suppressor function of p14 ARF and is indicative for pancreatic cancer prognosis
- (2021) Antje Repenning et al. EMBO JOURNAL
- The roles and regulation of MDM2 and MDMX: it is not just about p53
- (2021) Alyssa M. Klein et al. GENES & DEVELOPMENT
- Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence
- (2021) Zhong Wu et al. NATURE GENETICS
- Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand
- (2021) Parasvi S. Patel et al. ONCOGENE
- p53 and Tumor Suppression: It Takes a Network
- (2021) Anthony M. Boutelle et al. TRENDS IN CELL BIOLOGY
- CDKN2A Deletion in Melanoma Excludes T Cell Infiltration by Repressing Chemokine Expression in a Cell Cycle-Dependent Manner
- (2021) Zhen Zhu et al. Frontiers in Oncology
- Valosin-Containing Protein Stabilizes Mutant p53 to Promote Pancreatic Cancer Growth
- (2021) Jieqiong Wang et al. CANCER RESEARCH
- Proteogenomic characterization of pancreatic ductal adenocarcinoma
- (2021) Liwei Cao et al. CELL
- A proteogenomic portrait of lung squamous cell carcinoma
- (2021) Shankha Satpathy et al. CELL
- CDKN2A Alterations and Response to Immunotherapy in Solid Tumors
- (2021) Elio Adib et al. CLINICAL CANCER RESEARCH
- Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-Type TP53
- (2021) Mansoor N Saleh et al. CLINICAL CANCER RESEARCH
- Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration
- (2021) Francisco J. Sánchez-Rivera et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combinatorial CRISPR/Cas9 Screening Reveals Epistatic Networks of Interacting Tumor Suppressor Genes and Therapeutic Targets in Human Breast Cancer
- (2021) Xiaoyu Zhao et al. CANCER RESEARCH
- A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing
- (2021) Sanju Sinha et al. Nature Communications
- CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer
- (2021) Stanley I. Gutiontov et al. Scientific Reports
- The SETDB1–TRIM28 Complex Suppresses Antitumor Immunity
- (2021) Jianhuang Lin et al. Cancer Immunology Research
- MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling
- (2020) Divya Venkatesh et al. GENES & DEVELOPMENT
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model
- (2020) Nilay S. Sethi et al. NATURE GENETICS
- SENEBLOC, a long non-coding RNA suppresses senescence via p53-dependent and independent mechanisms
- (2020) Cheng Lin Xu et al. NUCLEIC ACIDS RESEARCH
- Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor–Host Feedback Signaling
- (2020) Iris Kamer et al. MOLECULAR CANCER RESEARCH
- Cas9 activates the p53 pathway and selects for p53-inactivating mutations
- (2020) Oana M. Enache et al. NATURE GENETICS
- Intrinsic and acquired resistance to CDK4/6 inhibitors and potential overcoming strategies
- (2020) Xia-qing Xu et al. ACTA PHARMACOLOGICA SINICA
- Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancer
- (2020) Leo Yamada et al. Gastric Cancer
- MDM2 inhibition: an important step forward in cancer therapy
- (2020) Marina Konopleva et al. LEUKEMIA
- The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
- (2020) Eliran Kadosh et al. NATURE
- Manumycin polyketides act as molecular glues between UBR7 and P53
- (2020) Yosuke Isobe et al. Nature Chemical Biology
- p53 programmes plough on
- (2020) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
- (2020) Sejin Oh et al. Nature Communications
- Anti-cancer peptides: classification, mechanism of action, reconstruction and modification
- (2020) Mingfeng Xie et al. Open Biology
- Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion
- (2020) Brian Koss et al. CANCER RESEARCH
- Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China
- (2020) Yu Xia et al. CURRENT GENE THERAPY
- Tumor suppressor p53: from engaging DNA to target gene regulation
- (2020) Morgan A Sammons et al. NUCLEIC ACIDS RESEARCH
- The m6A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor
- (2020) Yiren Xiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis
- (2020) Yu Chen Feng et al. Nature Communications
- Combined p14ARF and Interferon-β Gene Transfer to the Human Melanoma Cell Line SK-MEL-147 Promotes Oncolysis and Immune Activation
- (2020) Otto Luiz Dutra Cerqueira et al. Frontiers in Immunology
- mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression
- (2020) Ning Kon et al. GENES & DEVELOPMENT
- Opportunities and Challenges in Drug Development for Pediatric Cancers
- (2020) Theodore W. Laetsch et al. Cancer Discovery
- Upregulation of 5′-terminal oligopyrimidine mRNA translation upon loss of the ARF tumor suppressor
- (2020) Kyle A. Cottrell et al. Scientific Reports
- Homo-PROTAC mediated suicide of MDM2 to treat non-small cell lung cancer
- (2020) Shipeng He et al. Acta Pharmaceutica Sinica B
- The multiple mechanisms that regulate p53 activity and cell fate
- (2019) Antonina Hafner et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MDM2 Integrates Cellular Respiration and Apoptotic Signaling through NDUFS1 and the Mitochondrial Network
- (2019) Rana Elkholi et al. MOLECULAR CELL
- The molecular machinery of regulated cell death
- (2019) Daolin Tang et al. CELL RESEARCH
- Targeting p53-MDM2 interaction using small molecule inhibitors and the challenges needed to be addressed
- (2019) Maryam Zanjirband et al. CURRENT DRUG TARGETS
- Mechanistic basis for impaired ferroptosis in cells expressing the African-centric S47 variant of p53
- (2019) Julia I-Ju Leu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53
- (2019) Wei Wang et al. CANCER LETTERS
- Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics
- (2019) Anabel Sorolla et al. ONCOGENE
- Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy
- (2019) Boris Klimovich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic landscape of the tumor microenvironment at single cell resolution
- (2019) Zhengtao Xiao et al. Nature Communications
- Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition
- (2018) Jo Ishizawa et al. CANCER RESEARCH
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK2 Inhibitor for Treatment of Triple-negative Breast Cancer with a Compromised G1/S Checkpoint
- (2018) Dan Zhu et al. MOLECULAR CANCER THERAPEUTICS
- Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53
- (2018) Giuseppe Arena et al. MOLECULAR CELL
- CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response
- (2018) Emma Haapaniemi et al. NATURE MEDICINE
- Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia
- (2018) Luis A. Carvajal et al. Science Translational Medicine
- P53 and mTOR signalling determine fitness selection through cell competition during early mouse embryonic development
- (2018) Sarah Bowling et al. Nature Communications
- Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer
- (2018) Agnieszka K. Witkiewicz et al. Cell Reports
- p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
- (2018) Amy Tarangelo et al. Cell Reports
- p53 and the Viral Connection: Back into the Future ‡
- (2018) Ronit Aloni-Grinstein et al. Cancers
- Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
- (2018) Xiaotu Ma et al. NATURE
- MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
- (2018) John Hines et al. CANCER RESEARCH
- Peptide-based therapeutics: quality specifications, regulatory considerations, and prospects
- (2018) Shruti Rastogi et al. DRUG DISCOVERY TODAY
- Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression
- (2018) Yangbing Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mutant p53 sequestration of MDM2 acidic domain inhibits E3 ligase activity
- (2018) Leixiang Yang et al. MOLECULAR AND CELLULAR BIOLOGY
- mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53
- (2018) Seung Hee Jung et al. ONCOGENE
- Arginine-rich cell-penetrating peptides induce membrane multilamellarity and subsequently enter via formation of a fusion pore
- (2018) Christoph Allolio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aurora-A kinase inhibition is synthetic lethal with loss of the RB1 tumor suppressor gene
- (2018) Xueqian Gong et al. Cancer Discovery
- Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival
- (2018) Matthew G. Oser et al. Cancer Discovery
- Mitochondrial p32/C1qbp Is a Critical Regulator of Dendritic Cell Metabolism and Maturation
- (2018) Kazuhito Gotoh et al. Cell Reports
- Inhibition of MDM2 by a Rhein-Derived Compound AQ-101 Suppresses Cancer Development in SCID Mice
- (2017) Lubing Gu et al. MOLECULAR CANCER THERAPEUTICS
- NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
- (2017) Delin Chen et al. MOLECULAR CELL
- The most popular genes in the human genome
- (2017) NATURE
- CDK4/6 inhibition triggers anti-tumour immunity
- (2017) Shom Goel et al. NATURE
- Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase
- (2017) L E Giono et al. ONCOGENE
- p14ARF interacts with the focal adhesion kinase and protects cells from anoikis
- (2017) M Vivo et al. ONCOGENE
- Census and evaluation of p53 target genes
- (2017) M Fischer ONCOGENE
- Reviving the guardian of the genome: Small molecule activators of p53
- (2017) Daniel Nguyen et al. PHARMACOLOGY & THERAPEUTICS
- Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects ofArftumor suppressor-deficient mice
- (2017) Jolieke G. van Oosterwijk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anatomy of Mdm2 and Mdm4 in evolution
- (2017) Ban Xiong Tan et al. Journal of Molecular Cell Biology
- Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation
- (2017) David S. Liu et al. Nature Communications
- Protection against High-Fat-Diet-Induced Obesity in MDM2 C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure
- (2017) Shijie Liu et al. Cell Reports
- Conservation and Divergence of p53 Oscillation Dynamics across Species
- (2017) Jacob Stewart-Ornstein et al. Cell Systems
- Discovery of Dual Inhibitors of MDM2 and XIAP for Cancer Treatment
- (2016) Lubing Gu et al. CANCER CELL
- A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
- (2016) Alice Soragni et al. CANCER CELL
- 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway
- (2016) Jingwen Xu et al. CANCER LETTERS
- Peptide-based tumor inhibitor encoding mitochondrial p14ARFis highly efficacious to diverse tumors
- (2016) Ken Saito et al. CANCER SCIENCE
- Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer
- (2016) Anup Kumar Singh et al. CARCINOGENESIS
- The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans
- (2016) Cynthia R. Coffill et al. GENES & DEVELOPMENT
- An African-specific polymorphism in theTP53gene impairs p53 tumor suppressor function in a mouse model
- (2016) Matthew Jennis et al. GENES & DEVELOPMENT
- The role of the p53 tumor suppressor in metabolism and diabetes
- (2016) Che-Pei Kung et al. JOURNAL OF ENDOCRINOLOGY
- Rare cancers: a sea of opportunity
- (2016) Niki Boyd et al. LANCET ONCOLOGY
- Identification of a Small Molecule That Overcomes HdmX-Mediated Suppression of p53
- (2016) G. Karan et al. MOLECULAR CANCER THERAPEUTICS
- Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53
- (2016) Romain Riscal et al. MOLECULAR CELL
- Treating cancer with selective CDK4/6 inhibitors
- (2016) Ben O'Leary et al. Nature Reviews Clinical Oncology
- The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction
- (2016) Che-Pei Kung et al. Cell Reports
- Clinical Overview of MDM2/X-Targeted Therapies
- (2016) Andrew Burgess et al. Frontiers in Oncology
- The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
- (2016) Lioubov G. Korotchkina et al. Aging-US
- The MDM2 RING Domain and Central Acidic Domain Play Distinct Roles in MDM2 Protein Homodimerization and MDM2-MDMX Protein Heterodimerization
- (2015) Patrick L. Leslie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TRIM28 Is an E3 Ligase for ARF-Mediated NPM1/B23 SUMOylation That Represses Centrosome Amplification
- (2015) Shu Hui Neo et al. MOLECULAR AND CELLULAR BIOLOGY
- The p53 C Terminus Controls Site-Specific DNA Binding and Promotes Structural Changes within the Central DNA Binding Domain
- (2015) Oleg Laptenko et al. MOLECULAR CELL
- Ferroptosis as a p53-mediated activity during tumour suppression
- (2015) Le Jiang et al. NATURE
- Modulation of p53 during bacterial infections
- (2015) Christine Siegl et al. NATURE REVIEWS MICROBIOLOGY
- Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf–Mdm2–p53 and RP–Mdm2–p53 pathways
- (2015) X Meng et al. ONCOGENE
- PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence
- (2015) Lisa Ivanschitz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hitting cancers’ weak spots: vulnerabilities imposed by p53 mutation
- (2015) Evrim Gurpinar et al. TRENDS IN CELL BIOLOGY
- Targeting RING domains of Mdm2–MdmX E3 complex activates apoptotic arm of the p53 pathway in leukemia/lymphoma cells
- (2015) W Wu et al. Cell Death & Disease
- Intracellular CD24 disrupts the ARF–NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation
- (2015) Lizhong Wang et al. Nature Communications
- Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells
- (2015) Simona Daniele et al. Scientific Reports
- Probing Origin of Binding Difference of inhibitors to MDM2 and MDMX by Polarizable Molecular Dynamics Simulation and QM/MM-GBSA Calculation
- (2015) Jianzhong Chen et al. Scientific Reports
- A distinct p53 target gene set predicts for response to the selective p53–HDM2 inhibitor NVP-CGM097
- (2015) Sébastien Jeay et al. eLife
- BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function
- (2015) Xuetian Yue et al. eLife
- A Small-Molecule p53 Activator Induces Apoptosis through Inhibiting MDMX Expression in Breast Cancer Cells
- (2015) Hongbo Wang et al. NEOPLASIA
- ARF tumor suppression in the nucleolus
- (2014) Leonard B. Maggi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Regulation of p53 by Mdm2 E3 Ligase Function Is Dispensable in Embryogenesis and Development, but Essential in Response to DNA Damage
- (2014) Laura A. Tollini et al. CANCER CELL
- FL118 Induces p53-Dependent Senescence in Colorectal Cancer Cells by Promoting Degradation of MdmX
- (2014) X. Ling et al. CANCER RESEARCH
- Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo
- (2014) T J Phesse et al. CELL DEATH AND DIFFERENTIATION
- Role of p53 in Systemic Autoimmune Diseases
- (2014) Hiroaki Takatori et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Identification of a New Class of MDM2 Inhibitor That Inhibits Growth of Orthotopic Pancreatic Tumors in Mice
- (2014) Wei Wang et al. GASTROENTEROLOGY
- Nrf2- and ATF4-Dependent Upregulation of xCT Modulates the Sensitivity of T24 Bladder Carcinoma Cells to Proteasome Inhibition
- (2014) P. Ye et al. MOLECULAR AND CELLULAR BIOLOGY
- Identification of TRIML2, a Novel p53 Target, that Enhances p53 SUMOylation and Regulates the Transactivation of Proapoptotic Genes
- (2014) Che-Pei Kung et al. MOLECULAR CANCER RESEARCH
- Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5
- (2014) K Tago et al. ONCOGENE
- Inhibition of MDM2 by Nilotinib Contributes to Cytotoxicity in Both Philadelphia-Positive and Negative Acute Lymphoblastic Leukemia
- (2014) Hailong Zhang et al. PLoS One
- Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation
- (2014) Y. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A short acidic motif in ARF guards against mitochondrial dysfunction and melanoma susceptibility
- (2014) Claus Christensen et al. Nature Communications
- ARF and p53 Coordinate Tumor Suppression of an Oncogenic IFN-β-STAT1-ISG15 Signaling Axis
- (2014) Jason T. Forys et al. Cell Reports
- A conserved domain in exon 2 coding for the human and murine ARF tumor suppressor protein is required for autophagy induction
- (2013) Anna Budina-Kolomets et al. Autophagy
- Potentially functional variants ofp14ARFare associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy
- (2013) Xicheng Song et al. CARCINOGENESIS
- INK4a/ARF limits the expansion of cells suffering from replication stress
- (2013) Angela Monasor et al. CELL CYCLE
- A computational analysis of binding modes and conformation changes of MDM2 induced by p53 and inhibitor bindings
- (2013) Jianzhong Chen et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Antitumor Impact of p14ARF on Gefitinib-Resistant Non-Small Cell Lung Cancers
- (2013) K. Saito et al. MOLECULAR CANCER THERAPEUTICS
- ARF Represses Androgen Receptor Transactivation in Prostate Cancer
- (2013) Wenfu Lu et al. MOLECULAR ENDOCRINOLOGY
- The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation
- (2013) M J Kuchenreuther et al. ONCOGENE
- Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis
- (2013) A. I. Nieminen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets
- (2013) Ana Rita Carlos et al. Nature Communications
- Stapled Peptides with Improved Potency and Specificity That Activate p53
- (2012) Christopher J. Brown et al. ACS Chemical Biology
- A novel Aurora-A-mediated phosphorylation of p53 inhibits its interaction with MDM2
- (2012) Kai-Wei Hsueh et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers
- (2012) Pavlina Dolezelova et al. CELL CYCLE
- A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53
- (2012) Qi Zhang et al. EMBO Molecular Medicine
- p14ARF-induced Apoptosis in p53 Protein-deficient Cells Is Mediated by BH3-only Protein-independent Derepression of Bak Protein through Down-regulation of Mcl-1 and Bcl-xLProteins
- (2012) Annika Müer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery, Synthesis, and Biological Evaluation of Orally Active Pyrrolidone Derivatives as Novel Inhibitors of p53–MDM2 Protein–Protein Interaction
- (2012) Chunlin Zhuang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
- (2012) Oliver D. K. Maddocks et al. NATURE
- Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization
- (2012) B. Graves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p53 Dynamics Control Cell Fate
- (2012) J. E. Purvis et al. SCIENCE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Interaction of the ARF tumor suppressor with cytosolic HSP70 contributes to its autophagy function
- (2011) Julia Pimkina et al. CANCER BIOLOGY & THERAPY
- The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians
- (2011) Stian Knappskog et al. CANCER CELL
- p53 Binds to and Is Required for the Repression of Arf Tumor Suppressor by HDAC and Polycomb
- (2011) Y. Zeng et al. CANCER RESEARCH
- RNA Helicase DDX5 Is a p53-Independent Target of ARF That Participates in Ribosome Biogenesis
- (2011) A. J. Saporita et al. CANCER RESEARCH
- MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity
- (2011) Maren H. Stindt et al. CELL CYCLE
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- The evolution of MDM2 family genes
- (2011) Jamil Momand et al. GENE
- Hypergrowth mTORC1 Signals Translationally Activate the ARF Tumor Suppressor Checkpoint
- (2011) A. P. Miceli et al. MOLECULAR AND CELLULAR BIOLOGY
- The ARF Tumor Suppressor Inhibits Tumor Cell Colonization Independent of p53 in a Novel Mouse Model of Pancreatic Ductal Adenocarcinoma Metastasis
- (2011) V. P. Muniz et al. MOLECULAR CANCER RESEARCH
- Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells
- (2011) D. Li et al. MOLECULAR CANCER RESEARCH
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
- (2011) L. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors
- (2011) A V Vaseva et al. Cell Death & Disease
- Discovery of Mdm2-MdmX E3 Ligase Inhibitors Using a Cell-Based Ubiquitination Assay
- (2011) A. G. Herman et al. Cancer Discovery
- A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
- (2010) Federico Bernal et al. CANCER CELL
- An ARF-Independent c-MYC-Activated Tumor Suppression Pathway Mediated by Ribosomal Protein-Mdm2 Interaction
- (2010) Everardo Macias et al. CANCER CELL
- A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development
- (2010) Sean M. Post et al. CANCER CELL
- ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA
- (2010) Hiroyuki Kawagishi et al. CANCER RESEARCH
- Mdm2 and p53 are highly conserved from placozoans to man
- (2010) David P. Lane et al. CELL CYCLE
- S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response
- (2010) Keng Po Lai et al. EMBO JOURNAL
- Turning the RING Domain Protein MdmX into an Active Ubiquitin-Protein Ligase
- (2010) Saravanakumar Iyappan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification and Characterization of the First Small Molecule Inhibitor of MDMX
- (2010) Damon Reed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MDM2 Mediates Ubiquitination and Degradation of Activating Transcription Factor 3
- (2010) Pingli Mo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis
- (2010) Barbara Herkert et al. JOURNAL OF CELL BIOLOGY
- Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation
- (2010) V. Fogal et al. MOLECULAR AND CELLULAR BIOLOGY
- A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis
- (2010) H. Wang et al. MOLECULAR CANCER THERAPEUTICS
- The ARF Tumor Suppressor Controls Ribosome Biogenesis by Regulating the RNA Polymerase I Transcription Factor TTF-I
- (2010) Frédéric Lessard et al. MOLECULAR CELL
- An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis
- (2009) R C Kovi et al. CELL DEATH AND DIFFERENTIATION
- p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
- (2009) Shu-Ping Wang et al. NATURE CELL BIOLOGY
- p53 represses c-Myc through induction of the tumor suppressor miR-145
- (2009) M. Sachdeva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial p32 Is a Critical Mediator of ARF-Induced Apoptosis
- (2008) Koji Itahana et al. CANCER CELL
- p53-Dependent and p53-Independent Activation of Autophagy by ARF
- (2008) W. M. Abida et al. CANCER RESEARCH
- The ARF Tumor Suppressor Can Promote the Progression of Some Tumors
- (2008) O. Humbey et al. CANCER RESEARCH
- Acetylation Is Indispensable for p53 Activation
- (2008) Yi Tang et al. CELL
- p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
- (2008) Andrei V. Budanov et al. CELL
- The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
- (2008) T. Terzian et al. GENES & DEVELOPMENT
- ARF Induces Autophagy by Virtue of Interaction with Bcl-xl
- (2008) Julia Pimkina et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML
- (2008) K Kojima et al. LEUKEMIA
- Nucleophosmin Serves as a Rate-Limiting Nuclear Export Chaperone for the Mammalian Ribosome
- (2008) L. B. Maggi et al. MOLECULAR AND CELLULAR BIOLOGY
- Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines
- (2008) Eisaku Kondo et al. MOLECULAR CANCER THERAPEUTICS
- Characterization of a Novel Cytotoxic Cell‐penetrating Peptide Derived From p14ARF Protein
- (2007) Henrik J Johansson et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started